Biopharma News
FUJIFILM Diosynth Biotechnologies celebrates with ribbon cutting for latest manufacturing expansion
The Danish life science industry is getting another boost as FUJIFILM Diosynth Biotechnologies celebrates its recent production expansion in Denmark. Read more
14 Jan 2025
Danish protein analysis to revolutionise biopharma impurity control
Since 2007, the contract laboratory Alphalyse A/S has developed and refined a new method of impurity analysis in biological pharmaceuticals based on mass spectrometry (MS). Read more
8 Jan 2025
Everest Medicines announces positive results in Phase 1b/2a clinical trial
Everest Medicines has announced positive results in the ongoing Phase 1b/2a clinical trial for the treatment of primary membranous nephropathy (pMN) with EVER001 (previously known as XNW1011). Read more
9 Dec 2024
IMA Life announces partnership with RheaVita
IMA Life has announced a strategic partnership with RheaVita, a pioneer in controlled, continuous freeze-drying technology for biopharmaceuticals. Read more
21 Nov 2024
Pheast presents new preclinical data for anti-CD24 macrophage checkpoint inhibitor
Pheast Therapeutics announced the presentation of new preclinical data for PHST001, an anti-CD24 antibody drug candidate that is designed to block a key macrophage "don't eat me" signal on cancer cells. Read more
12 Nov 2024
iotaSciences launches fast single-cell cloning platform for gene therapy
iotaSciences announced the upcoming launch of its newly developed Single-Cell Cloning Platform XT at the Cell 2024 event in London (UK) from November 6-8, 2024. Read more
5 Nov 2024
Planova FG1 brings a step forward in biopharma manufacturing
Koki Obara, marketing manager, Asahi Kasei Medical, delves into the current biopharmaceutical environment, the critical role of virus removal filters, and how Planova FG1 stands to impact the development and production of biopharmaceuticals. Read more
3 Dec 2024
Leqembi, Donanemab and Tofersen: The End of the Journey or the First Step on the Road to Reversing Neurodegeneration?
Dr. Peter Hamley, Chief Scientific Officer at Samsara Therapeutics, explores whether developments in therapeutics for neurodegenerative diseases are truly disease modifying or addressing the symptoms of a deeper problem. Read more
16 Aug 2023
R&D revolution: A new paradigm of sourcing and landscaping for the pharma industry
Dr Robin Knight, Co-Founder & Co-CEO of IN-PART, discusses the emerging importance of outsourcing landscaping activities within the pharmaceuticals industry and the benefits of adopting an openly innovative approach that pools sources of innovation. Read more
12 Jul 2023
Why Pharmaceutical Industry Needs a Digital Content Factory (DCF)?
Modern pharma brands pursue a higher degree of content personalisation to engage with diverse audiences. This means tighter deadlines, higher workloads, and a greater demand for skilled content creators than ever before. Read more
Surface Acoustic Wave: flow measurement and prevention of biofilm in WFI loops
Flow control specialist Bürkert has developed a flowmeter that uses Surface Acoustic Wave (SAW) technology that also helps to prevent the formation of biofilms in Water for Injection (WFI) loops. Read more
16 Jan 2025
Pharma Manufacturing News + Pharmaceutical Manufacturing News
GEODIS Management Board appoints executive VP
GEODIS, specialist in transport and logistics, announces the appointment of Marc Vollet as executive vice-president of GEODIS’s European Road Network Line of Business. Read more
15 Jan 2025
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Phillips Medisize expands its inhalation drug delivery capabilities
Molex, a parent to Phillips Medisize, announced that it has completed, through an affiliate, the previously announced acquisition of Vectura Group from Vectura Fertin Pharma, a subsidiary of Philip Morris International. Read more
15 Jan 2025
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
CARBOGEN AMCIS passes Swissmedic inspection
The inspection process primarily focused on Quality Management System compliance regarding the development and manufacture of highly potent APIs. Read more
14 Jan 2025
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Everest Medicines implements NEFECON reimbursement pricing in China
Everest Medicines has announced that with the official implementation of the latest update of the National Reimbursement Drug List on 1st January 2025, NEFECON(R) will apply the NRDL pricing, which will benefit more IgA nephropathy (IgAN) patients. Read more
9 Jan 2025
Pharma Manufacturing News + New Drug Development & Regulatory News
Lonza Capsules expands capsule manufacturing capacity in India and China
Lonza, a global manufacturing partner to the pharmaceutical, biotech and nutraceutical markets, has announced capacity expansions at its sites in Rewari (IN) and Suzhou (CN). Read more
9 Jan 2025
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News